Cita APA

Veeraraghavan, J., Angelis, C. D., Mao, R., Wang, T., Herrera, S., Pavlick, A. C., . . . Schiff, R. (2019). A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. Ann Oncol.

Citación estilo Chicago

Veeraraghavan, J., et al. "A Combinatorial Biomarker Predicts Pathologic Complete Response to Neoadjuvant Lapatinib and Trastuzumab Without Chemotherapy in Patients With HER2+ Breast Cancer." Ann Oncol 2019.

Cita MLA

Veeraraghavan, J., et al. "A Combinatorial Biomarker Predicts Pathologic Complete Response to Neoadjuvant Lapatinib and Trastuzumab Without Chemotherapy in Patients With HER2+ Breast Cancer." Ann Oncol 2019.